↓ Skip to main content

PTEN is a negative regulator of mitotic checkpoint complex during the cell cycle

Overview of attention for article published in Experimental Hematology & Oncology, June 2017
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PTEN is a negative regulator of mitotic checkpoint complex during the cell cycle
Published in
Experimental Hematology & Oncology, June 2017
DOI 10.1186/s40164-017-0079-0
Pubmed ID
Authors

Byeong H. Choi, Steve Xie, Wei Dai

Abstract

Nuclear PTEN plays an important role during mitosis. To understand the molecular basis by which PTEN mediates mitotic progression, we examined whether PTEN regulated the formation of mitotic checkpoint complex (MCC). We observed that arsenic trioxide, a mitotic inducer, stimulated nuclear translocation of PTEN in a time-dependent manner. PTEN physically interacted with Cdc20 and Mad2, two important components of MCC. Arsenic treatment diminished the physical association of PTEN with BubR1 and Bub3 but not with Cdc20 and Mad2. Our further studies revealed that downregulation of PTEN via RNAi enhanced formation of MCC during the cell cycle. Moreover, PTEN silencing induced chromosomal instability. Given the crucial role of PTEN in suppressing tumor development, our study strongly suggests that PTEN also functions to maintain chromosomal stability, partly through suppressing unscheduled formation of MCC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 46%
Researcher 3 23%
Student > Bachelor 2 15%
Other 1 8%
Student > Postgraduate 1 8%
Other 0 0%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 23%
Medicine and Dentistry 3 23%
Environmental Science 2 15%
Agricultural and Biological Sciences 1 8%
Immunology and Microbiology 1 8%
Other 1 8%
Unknown 2 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2017.
All research outputs
#22,784,474
of 25,402,528 outputs
Outputs from Experimental Hematology & Oncology
#307
of 367 outputs
Outputs of similar age
#287,490
of 328,320 outputs
Outputs of similar age from Experimental Hematology & Oncology
#7
of 7 outputs
Altmetric has tracked 25,402,528 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 367 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,320 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.